Related Experiment Video
Updated: Feb 19, 2026

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
Published on: October 3, 2019
A Therapeutic Double Whammy: Transcriptional or Post-transcriptional Suppression of Microsatellite Repeat Toxicity by
Ashish N Rao1, Thomas A Cooper2
1Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030, USA.
Abstract:
Microsatellite expansion diseases are caused by unstable tandem repeats of 3-10 nucleotides that become pathogenic beyond a threshold number of copies. Two groups present different approaches to reduce pathogenesis by targeting deactivated Cas9 to either the DNA (Pinto et al., 2017) or the RNA (Batra et al., 2017) repeats with therapeutic potential for several diseases.
Insights
Microsatellite expansion diseases stem from unstable DNA repeats. Researchers are exploring CRISPR-based strategies, targeting either DNA or RNA, to reduce pathogenic repeat numbers and treat these conditions.
Area of Science:
- Genetics
- Molecular Biology
- Biotechnology
Background:
- Microsatellite expansion diseases arise from unstable tandem DNA repeats exceeding a pathogenic threshold.
- These repeat expansions are implicated in various genetic disorders.
Purpose of the Study:
- To explore novel therapeutic strategies for microsatellite expansion diseases.
- To evaluate the potential of targeting repeat expansions using deactivated Cas9 (dCas9) systems.
Main Methods:
- Two distinct approaches utilizing dCas9 were investigated.
- One strategy targeted the DNA repeats directly.
- The other strategy targeted the RNA transcripts of the repeats.
Main Results:
- Both DNA-targeting and RNA-targeting dCas9 strategies demonstrated potential in reducing pathogenic repeat numbers.
- These findings suggest distinct therapeutic avenues for microsatellite expansion disorders.
Conclusions:
- Targeting either DNA or RNA repeats with dCas9 offers a promising therapeutic avenue for microsatellite expansion diseases.
- Further research into these CRISPR-based interventions could lead to effective treatments.
Related Concept Videos
CRISPR
CRISPR/Cas9 Genome Editing
Homologous Recombination
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...

